Toyoda M - Search Results

1

Immunomodulatory actions of intravenous immunoglobulin (IVIG): potential applications in solid organ transplant recipients.

Jordan SC, Tyan D, Czer L, Toyoda M. Jordan SC, et al. Among authors: toyoda m. Pediatr Transplant. 1998 May;2(2):92-105. Pediatr Transplant. 1998. PMID: 10082441 Review.

2

Immunomodulatory effects of combination of pooled human gammaglobulin and rapamycin on cell proliferation and apoptosis in the mixed lymphocyte reaction.

Toyoda M, Petrosyan A, Pao A, Jordan SC. Toyoda M, et al. Transplantation. 2004 Oct 27;78(8):1134-8. doi: 10.1097/01.tp.0000134974.16614.ea. Transplantation. 2004. PMID: 15502709

3

Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial.

Jordan SC, Tyan D, Stablein D, McIntosh M, Rose S, Vo A, Toyoda M, Davis C, Shapiro R, Adey D, Milliner D, Graff R, Steiner R, Ciancio G, Sahney S, Light J. Jordan SC, et al. Among authors: toyoda m. J Am Soc Nephrol. 2004 Dec;15(12):3256-62. doi: 10.1097/01.ASN.0000145878.92906.9F. J Am Soc Nephrol. 2004. PMID: 15579530 Clinical Trial.

4

Post-transplant therapy with high-dose intravenous gammaglobulin: Applications to treatment of antibody-mediated rejection.

Jordan SC, Vo AA, Toyoda M, Tyan D, Nast CC. Jordan SC, et al. Among authors: toyoda m. Pediatr Transplant. 2005 Apr;9(2):155-61. doi: 10.1111/j.1399-3046.2005.00256.x. Pediatr Transplant. 2005. PMID: 15787786 Review.

5

Current approaches to treatment of antibody-mediated rejection.

Jordan SC, Vo AA, Tyan D, Nast CC, Toyoda M. Jordan SC, et al. Among authors: toyoda m. Pediatr Transplant. 2005 Jun;9(3):408-15. doi: 10.1111/j.1399-3046.2005.00363.x. Pediatr Transplant. 2005. PMID: 15910400 Review.

6

Intravenous immunoglobulin a natural regulator of immunity and inflammation.

Jordan SC, Toyoda M, Vo AA. Jordan SC, et al. Among authors: toyoda m. Transplantation. 2009 Jul 15;88(1):1-6. doi: 10.1097/TP.0b013e3181a9e89a. Transplantation. 2009. PMID: 19584672 Review.

7

Use of intravenous immune globulin and rituximab for desensitization of highly HLA-sensitized patients awaiting kidney transplantation.

Vo AA, Peng A, Toyoda M, Kahwaji J, Cao K, Lai CH, Reinsmoen NL, Villicana R, Jordan SC. Vo AA, et al. Among authors: toyoda m. Transplantation. 2010 May 15;89(9):1095-102. doi: 10.1097/TP.0b013e3181d21e7f. Transplantation. 2010. PMID: 20110854

8

Regulation of immunity and inflammation by intravenous immunoglobulin: relevance to solid organ transplantation.

Jordan SC, Toyoda M, Vo AA. Jordan SC, et al. Among authors: toyoda m. Expert Rev Clin Immunol. 2011 May;7(3):341-8. doi: 10.1586/eci.11.10. Expert Rev Clin Immunol. 2011. PMID: 21595600 Review.

9

Polyomavirus BK viremia in kidney transplant recipients after desensitization with IVIG and rituximab.

Barbosa D, Kahwaji J, Puliyanda D, Mirocha J, Reinsmoen N, Lai CH, Villicana R, Peng A, Jordan SC, Vo A, Toyoda M. Barbosa D, et al. Among authors: toyoda m. Transplantation. 2014 Apr 15;97(7):755-61. doi: 10.1097/01.TP.0000437671.78716.f3. Transplantation. 2014. PMID: 24686425

10

Benefits of rituximab combined with intravenous immunoglobulin for desensitization in kidney transplant recipients.

Vo AA, Choi J, Cisneros K, Reinsmoen N, Haas M, Ge S, Toyoda M, Kahwaji J, Peng A, Villicana R, Jordan SC. Vo AA, et al. Among authors: toyoda m. Transplantation. 2014 Aug 15;98(3):312-9. doi: 10.1097/TP.0000000000000064. Transplantation. 2014. PMID: 24770617 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,053 results

Search Page

Filters